Neuromedical
The business, the turning points, and the decisions behind them.
Some sections are still being researched2 / 4
Sections to complete：02 · 05
01 / WHAT IT BUILT
What the company did
Neuromedical is a Polish med-tech company developing the Vguard device: non-invasive transcutaneous vagus nerve stimulation (tVNS) delivered during sleep to support memory consolidation and slow cognitive decline in patients with mild cognitive impairment and early-stage Alzheimer's disease. Designed for at-home use under a hardware-as-a-service model, it transmits treatment data directly to supervising physicians. Based in Lodz, Poland, the company holds CE/MDR certification for Europe, is running multi-center clinical trials, and is pursuing FDA approval.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Founded
Neuromedical was founded in Lodz, Poland, to develop vagus nerve stimulation therapy for cognitive decline.
- Vguard clinical testing
After completing preclinical work and first trials on 30 patients, the company began recruiting volunteers for the next phase of Vguard testing.
- Raised 1.3M EUR
The company raised 1.3 million euros (PLN 5.5 million), led by Hard2beat with angel investors, to advance at-home Alzheimer's therapy toward a planned 2026 Poland launch.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN / AFTERMATH
Material for this section is being gathered and checked. It will appear here once ready.